Researchers at Children's Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for ...

Longeveron Inc. has completed enrollment for its Phase 2b clinical trial, ELPIS II, which is testing laromestrocel, a cellular therapy aimed at improving outcomes in infants with Hypoplastic Left ...

Background Population studies of congenital heart disease (CHD) often include only children receiving cardiac interventions, underestimating the burden of cases without intervention. We evaluated ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...